Personalised cancer vaccine cuts risk of deadly skin cancer returning by 42% in major trial A personalized cancer vaccine created from the same mRNA technology used for COVID-19 vaccines has shown 42% protection against the return of aggressive skin cancer, bringing hope for a new. ..



